These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12217393)

  • 21. Cutting Edge: Transmembrane phosphoprotein Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomains as a negative feedback regulator of mast cell signaling through the FcepsilonRI.
    Ohtake H; Ichikawa N; Okada M; Yamashita T
    J Immunol; 2002 Mar; 168(5):2087-90. PubMed ID: 11859092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane receptor mapping: the membrane topography of Fc(epsilon)RI signaling.
    Oliver JM; Pfeiffer JR; Surviladze Z; Steinberg SL; Leiderman K; Sanders ML; Wofsy C; Zhang J; Fan H; Andrews N; Bunge S; Boyle TJ; Kotula P; Wilson BS
    Subcell Biochem; 2004; 37():3-34. PubMed ID: 15376617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine phosphorylation of the linker for activator of T cells in mast cells by stimulation with the high affinity IgE receptor.
    Kimura T; Hisano M; Inoue Y; Adachi M
    Immunol Lett; 2001 Jan; 75(2):123-9. PubMed ID: 11137136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of rat basophilic leukemia-2H3 mast cell secretion by a constitutive Lyn kinase interaction with the high affinity IgE receptor (Fc epsilon RI).
    Vonakis BM; Gibbons SP; Rotté MJ; Brothers EA; Kim SC; Chichester K; MacDonald SM
    J Immunol; 2005 Oct; 175(7):4543-54. PubMed ID: 16177098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mechanistic model of early FcεRI signaling: lipid rafts and the question of protection from dephosphorylation.
    Barua D; Goldstein B
    PLoS One; 2012; 7(12):e51669. PubMed ID: 23284735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.
    Kovárová M; Tolar P; Arudchandran R; Dráberová L; Rivera J; Dráber P
    Mol Cell Biol; 2001 Dec; 21(24):8318-28. PubMed ID: 11713268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein tyrosine kinase Syk in mast cell signaling.
    Siraganian RP; Zhang J; Suzuki K; Sada K
    Mol Immunol; 2002 Sep; 38(16-18):1229-33. PubMed ID: 12217388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of mast cell signaling through high-affinity IgE receptor by CD45 protein tyrosine phosphatase.
    Murakami K; Sato S; Nagasawa S; Yamashita T
    Int Immunol; 2000 Feb; 12(2):169-76. PubMed ID: 10653852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival.
    Kitaura J; Xiao W; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Kawakami T
    J Immunol; 2004 Oct; 173(7):4317-23. PubMed ID: 15383560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
    Zhang J; Siraganian RP
    J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TOM1L1 is a Lyn substrate involved in FcepsilonRI signaling in mast cells.
    Zhang J; Suzuki K; Hitomi T; Siraganian RP
    J Biol Chem; 2007 Dec; 282(52):37669-77. PubMed ID: 17977829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells.
    Kim DK; Kim HS; Kim AR; Jang GH; Kim HW; Park YH; Kim B; Park YM; Beaven MA; Kim YM; Choi WS
    Sci Signal; 2013 Sep; 6(292):ra80. PubMed ID: 24023254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docking of Syk to FcεRI is enhanced by Lyn but limited in duration by SHIP1.
    Kanagy WK; Cleyrat C; Fazel M; Lucero SR; Bruchez MP; Lidke KA; Wilson BS; Lidke DS
    Mol Biol Cell; 2022 Sep; 33(10):ar89. PubMed ID: 35793126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release.
    Suzuki Y; Yoshimaru T; Yamashita K; Matsui T; Yamaki M; Shimizu K
    Biochem Biophys Res Commun; 2001 May; 283(3):707-14. PubMed ID: 11341783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adapter molecule Gab2 regulates Fc epsilon RI-mediated signal transduction in mast cells.
    Xie ZH; Ambudkar I; Siraganian RP
    J Immunol; 2002 May; 168(9):4682-91. PubMed ID: 11971018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of FcepsilonRI-mediated signaling by an adaptor protein STAP-2/BSK in rat basophilic leukemia RBL-2H3 cells.
    Yamamoto T; Yumioka T; Sekine Y; Sato N; Minoguchi M; Yoshimura A; Matsuda T
    Biochem Biophys Res Commun; 2003 Jul; 306(3):767-73. PubMed ID: 12810085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of xanthones isolated from the pericarp of Garcinia mangostana L. on rat basophilic leukemia RBL-2H3 cell degranulation.
    Itoh T; Ohguchi K; Iinuma M; Nozawa Y; Akao Y
    Bioorg Med Chem; 2008 Apr; 16(8):4500-8. PubMed ID: 18328716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silver activates calcium signals in rat basophilic leukemia-2H3 mast cells by a mechanism that differs from the Fc epsilon RI-activated response.
    Suzuki Y; Yoshimaru T; Matsui T; Ra C
    J Immunol; 2002 Oct; 169(7):3954-62. PubMed ID: 12244196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
    Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
    J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.